1 JANUARY – 30 SEPTEMBER 2007 (compared with the same period previous year)
• Net sales amounted to SEK 78,105m (75,789).
• Profit before tax amounted to SEK 5,895m (5,030), an improvement of 17%.
• Net profit for the period amounted to SEK 5,023m (4,016).
• Earnings per share amounted to SEK 7.13 (5.70).
• Cash flow from current operations amounted to SEK 3,105m (1,549), an improvement of 100%.
• Net cash flow amounted to SEK 1,565m (-1,781).
“The improvement in earnings compared with the previous year continues. Profit before tax is 17% higher and all business areas improved their operating profit. At the same time, SCA’s operations maintained the earnings level from the strong second quarter and once again report a profit before tax in excess of SEK 2 billion.
Demand for the Group’s products remains high with opportunities for further price improvements while raw material and energy costs are expected to be higher than during the third quarter.
The acquisition of Procter & Gamble’s tissue operations marks a key strategic step in the work of improving SCA’s tissue operations in Europe. The deal was closed on 1 October and has clearly strengthened SCA’s leading position in Europe.”
acting President and CEO
A press conference will be held today, October 31, at 10.30 CET. For further details, see www.sca.com.
Stockholm, 31 October 2007
For further information, please contact:
Bodil Eriksson, Corporate Communications, +46 8 788 52 34
Johan Karlsson, Investor Relations, +46 8 788 51 30
Pär Altan, Media Relations, +46 8 788 52 37
SCA discloses the information provided herein pursuant to the Swedish Securities Exchange and Clearing Operations Act. The information was submitted for publication at 08.00 CET on 31 October 2007.
This report has been prepared in both Swedish and English. In case of variation in the content of the two versions, the Swedish version shall prevail. The report has not been reviewed by the company’s auditors.